Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence

PLoS Pathogens

Volumn 3, Issue 6, 2007, Pages 0752-0769

  Mäurer, André P ^a   Mehlitz, Adrian ^a   Mollenkopf, Hans J ^a   Meyer, Thomas F ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN CWL029; PROTEIN DERIVATIVE; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; IRON; PROTEASOME;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE MAPPING; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INFECTION; IRON DEPLETION; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PROTEOMICS; TRANSCRIPTOMICS; ACUTE DISEASE; CELL LINE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; MULTIGENE FAMILY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHLAMYDOPHILA PNEUMONIAE; NEGIBACTERIA;

ACUTE DISEASE; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; GENE EXPRESSION PROFILING; HUMANS; IRON; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 34347335735     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0030083     Document Type: Article

References (103)

1. Moulder JW (1991) Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55: 143-190.
2. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, et al. (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A 92: 6911-6914.
3. Blasi F (2004) Atypical pathogens and respiratory tract infections. Eur Respir J 24: 171-181.
4. Stocks N, Turnidge J, Crockett A (2004) Lower respiratory tract infections and community acquired pneumonia in adults. Aust Fam Physician 33: 297-301.
5. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181 Suppl 3: S402-S410.
6. Ferrari M, Poli A, Olivieri M, Verlato G, Tardivo S (2002) Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults. Infection 30: 203-207.
7. Hannu T, Puolakkainen M, Leirisalo-Repo M (1999) Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) 38: 411-414.
8. von HL (2002) Role of persistent infection in the control and severity of asthma: Focus on Chlamydia pneumoniae. Eur Respir J 19: 546-556.
9. Hahn DL, Dodge RW, Golubjatnikov R (1991) Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266: 225-230.
10. Huittinen T, Hahn D, Anttila T, Wahlstrom E, Saikku P, et al. (2001) Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur Respir J 17: 1078-1082.
11. Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, et al. (2003) The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J Allergy Clin Immunol 112: 729-734.
12. Karnak D, Beng-sun S, Beder S, Kayacan O (2001) Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med 95: 811-816.
13. Mahony JB, Coombes BK (2001) Chlamydia pneumoniae and atherosclerosis: Does the evidence support a causal or contributory role? FEMS Microbiol Lett 197: 1-9.
14. Rosenfeld ME, Blessing E, Lin TM, Moazed TC, Campbell LA, et al. (2000) Chlamydia, inflammation, and atherogenesis. J Infect Dis 181 Suppl 3: S492-S497.
15. Hauer AD, de Vos P, Peterse N, ten Cate H, van Berkel TJ, et al. (2006) Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice. Cardiovasc Res 69: 280-288.
16. Hammerschlag MR (2002) The intracellular life of chlamydiae. Semin Pediatr Infect Dis 13: 239-248.
17. Heinzen RA, Scidmore MA, Rockey DD, Hackstadt T (1996) Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun 64: 796-809.
18. Fields KA, Hackstadt T (2002) The chlamydial inclusion: Escape from the endocytic pathway. Annu Rev Cell Dev Biol 18: 221-245.
19. Taraska T, Ward DM, Ajioka RS, Wyrick PB, Davis-Kaplan SR, et al. (1996) The late chlamydial inclusion membrane is not derived from the endocytic pathway and is relatively deficient in host proteins. Infect Immun 64: 3713-3727.
20. Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, et al. (2000) Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol 37: 913-925.
21. Beatty WL, Morrison RP, Byrne GI (1994) Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58: 686-699.
22. Clark RB, Schatzki PF, Dalton HP (1982) Ultrastructural effect of penicillin and cycloheximide on Chlamydia trachomatis strain HAR-13. Med Microbiol Immunol 171: 151-159.
23. Beatty WL, Morrison RP, Byrne GI (1995) Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun 63: 199-205.
24. Tribby II, Friis RR, Moulder JW (1973) Effect of chloramphenicol, rifampicin, and nalidixic acid on Chlamydia psittaci growing in L cells. J Infect Dis 127: 155-163.
25. Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT (2001) Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun 69: 7927-7932.
26. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA (1995) Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 63: 2801-2803.
27. Shemer Y, Sarov I (1985) Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect Immun 48: 592-596.
28. Rothermel CD, Byrne GI, Havell EA (1983) Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect Immun 39: 362-370.
29. Byrne GI, Lehmann LK, Landry GJ (1986) Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 53: 347-351.
30. Coles AM, Reynolds DJ, Harper A, Devitt A, Pearce JH (1993) Low-nutrient induction of abnormal chlamydial development: A novel component of chlamydial pathogenesis? FEMS Microbiol Lett 106: 193-200.
31. Harper A, Pogson CI, Jones ML, Pearce JH (2000) Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect Immun 68: 1457-1464.
32. Al Younes HM, Rudel T, Brinkmann V, Szczepek AJ, Meyer TF (2001) Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol 3: 427-437.
33. Wehrl W, Meyer TF, Jungblut PR, Muller EC, Szczepek AJ (2004) Action and reaction: Chlamydophila pneumoniae proteome alteration in a persistent infection induced by iron deficiency. Proteomics 4: 2969-2981.
34. Raulston JE (1997) Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 65: 4539-4547.
35. Sullivan JL, Weinberg ED (1999) Iron and the role of Chlamydia pneumoniae in heart disease. Emerg Infect Dis 5: 724-726.
36. Ishihara T, Aga M, Hino K, Ushio C, Taniguchi M, et al. (2005) Inhibition of Chlamydia trachomatis growth by human interferon-alpha: Mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. Biomed Res 26: 179-185.
37. Alpert PT (2004) New and emerging theories of cardiovascular disease: Infection and elevated iron. Biol Res Nurs 6: 3-10.
38. Kelver ME, Kaul A, Nowicki B, Findley WE, Hutchens TW, et al. (1996) Estrogen regulation of lactoferrin expression in human endometrium. Am J Reprod Immunol 36: 243-247.
39. Ponka P (1999) Cellular iron metabolism. Kidney Int Suppl 69: S2-S11.
40. Schaible UE, Kaufmann SH (2004) Iron and microbial infection. Nat Rev Microbiol 2: 946-953.
41. Weinberg ED (1984) Iron withholding: A defense against infection and neoplasia. Physiol Rev 64: 65-102.
42. Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, et al. (2003) Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 100: 8478-8483.
43. Nicholson TL, Olinger L, Chong K, Schoolnik G, Stephens RS (2003) Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. J Bacteriol 185: 3179-3189.
44. Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, et al. (2003) Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A 100: 15971-15976.
45. Goellner S, Schubert E, Liebler-Tenorio E, Hotzel H, Saluz HP, Sachse K (2006) Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect Immun 74: 4801-4808.
46. Byrne GI, Ouellette SP, Wang Z, Rao JP, Lu L, et al. (2001) Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun 69: 5423-5429.
47. Mathews S, George C, Flegg C, Stenzel D, Timms P (2001) Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathog 30: 337-345.
48. Slepenkin A, Motin V, de la Maza LM, Peterson EM (2003) Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect Immun 71: 2555-2562.
49. Hogan RJ, Mathews SA, Kutlin A, Hammerschlag MR, Timms P (2003) Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microb Pathog 34: 11-16.
50. Brickman TJ, Barry CE III, Hackstadt T (1993) Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J Bacteriol 175: 4274-4281.
51. Barry CE III, Brickman TJ, Hackstadt T (1993) Hc1-mediated effects on DNA structure: A potential regulator of chlamydial development. Mol Microbiol 9: 273-283.
52. Hatch TP, Miceli M, Sublett JE (1986) Synthesis of disulfide-bonded outer membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J Bacteriol 165: 379-385.
53. Ouellette SP, Hatch TP, Abdelrahman YM, Rose LA, Belland RJ, et al. (2006) Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNgamma-mediated host cell tryptophan starvation. Mol Microbiol 62: 1387-1401.
54. Arfin SM, Long AD, Ito ET, Tolleri L, Riehle MM, et al. (2000) Global gene expression profiling in Escherichia coli K12. The effects of integration host factor. J Biol Chem 275: 29672-29684.
55. Talaat AM, Hunter P, Johnston SA (2000) Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis. Nat Biotechnol 18: 679-682.
56. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
57. Kaul R, Hoang A, Yau P, Bradbury EM, Wenman WM (1997) The chlamydial EUO gene encodes a histone H1-specific protease. J Bacteriol 179: 5928-5934.
58. Zhang L, Douglas AL, Hatch TP (1998) Characterization of a Chlamydia psittaci DNA binding protein (EUO) synthesized during the early and middle phases of the developmental cycle. Infect Immun 66: 1167-1173.
59. Zhang L, Howe MM, Hatch TP (2000) Characterization of in vitro DNA binding sites of the EUO protein of Chlamydia psittaci. Infect Immun 68: 1337-1349.
60. Hackstadt T, Baehr W, Ying Y (1991) Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. Proc Natl Acad Sci U S A 88: 3937-3941.
61. Gerard HC, Krausse-Opatz B, Wang Z, Rudy D, Rao JP, et al. (2001) Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol 41: 731-741.
62. Kim CC, Falkow S (2003) Significance analysis of lexical bias in microarray data. BMC Bioinformatics 4: 12.
63. Vandahl BB, Birkelund S, Demol H, Hoorelbeke B, Christiansen G, et al. (2001) Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 22: 1204-1223.
64. Kalman S, Mitchell W, Marathe R, Lammel C, Fan J, et al. (1999) Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet 21: 385-389.
65. Müller M (2004) Persistent bacterial infections: Identification of immunogenic structures of Borrelia burgdorferi sensu lato and Chlamydophila pneumoniae by phage surface display [dissertation]. Konstanz (Germany): Universität Konstanz. 139 p. Available: http://deposit.ddb.de/cgi-bin/ dokserv?idn=970982135. Accessed 13 May 2007.
66. Vandahl BB, Pedersen AS, Gevaert K, Holm A, Vandekerckhove J, et al. (2002) The expression, processing and localization of polymorphic membrane proteins in Chlamydia pneumoniae strain CWL029. BMC Microbiol 2: 36.
67. Wehrl W, Brinkmann V, Jungblut PR, Meyer TF, Szczepek AJ (2004) From the inside out - Processing of the Chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells. Mol Microbiol 51: 319-334.
68. Rothfield L, Justice S, Garcia-Lara J (1999) Bacterial cell division. Annu Rev Genet 33: 423-448.
69. Bramhill D (1997) Bacterial cell division. Annu Rev Cell Dev Biol 13: 395-424.
70. Heuer D, Brinkmann V, Meyer TF, Szczepek AJ (2003) Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol 5: 315-322.
71. Read TD, Brunham RC, Shen C, Gill SR, Heidelberg JF, et al. (2000) Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28: 1397-1406.
72. Shirai M, Hirakawa H, Kimoto M, Tabuchi M, Kishi F, et al. (2000) Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res 28: 2311-2314.
73. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, et al. (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754-759.
74. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S, et al. (2005) A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56: 1636-1647.
75. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, et al. (2006) From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res 34: D354-D357.
76. Suzuki M, Hara H, Matsumoto K (2002) Envelope disorder of Escherichia coli cells lacking phosphatidylglycerol. J Bacteriol 184: 5418-5425.
77. Studholme DJ, Buck M (2000) The biology of enhancer-dependent transcriptional regulation in bacteria: Insights from genome sequences. FEMS Microbiol Lett 186: 1-9.
78. Douglas AL, Hatch TP (2000) Expression of the transcripts of the sigma factors and putative sigma factor regulators of Chlamydia trachomatis L2. Gene 247: 209-214.
79. Yu HH, Tan M (2003) Sigma28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia. Mol Microbiol 50: 577-584.
80. Yu HH, Kibler D, Tan M (2006) In silico prediction and functional validation of sigma28-regulated genes in Chlamydia and Escherichia coli. J Bacteriol 188: 8206-8212.
81. Mathews SA, Volp KM, Timms P (1999) Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of sigma factors. FEBS Lett 458: 354-358.
82. Kubo A, Stephens RS (2001) Substrate-specific diffusion of select dicarboxylates through Chlamydia trachomatis PorB. Microbiology 147: 3135-3140.
83. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P (2004) Chlamydial persistence: Beyond the biphasic paradigm. Infect Immun 72: 1843-1855.
84. Henriques AO, Glaser P, Piggot PJ, Moran CP Jr (1998) Control of cell shape and elongation by the rodA gene in Bacillus subtilis. Mol Microbiol 28: 235-247.
85. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, et al. (1999) Housekeeping genes as internal standards: Use and limits. J Biotechnol 75: 291-295.
86. Ryo A, Suzuki Y, Arai M, Kondoh N, Wakatsuki T, et al. (2000) Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells. AIDS Res Hum Retroviruses 16: 995-1005.
87. Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193.
88. Solanas M, Moral R, Escrich E (2001) Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. Anal Biochem 288: 99-102.
89. Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M (2000) Comparison of human adult and fetal expression and identification of 535 housekeeping/ maintenance genes. Physiol Genomics 2: 143-147.
90. Johnson ML, Redmer DA, Reynolds LP (1995) Quantification of lane-to-lane loading of poly(A) RNA using a biotinylated oligo(dT) probe and chemiluminescent detection. Biotechniques 19: 712-715.
91. Warner JR (1999) The economics of ribosome biosynthesis in yeast. Trends Biochem Sci 24: 437-440.
92. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
93. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
94. Liu MY, Gui G, Wei B, Preston JF III, Oakford L, et al. (1997) The RNA molecule CsrB binds to the global regulatory protein CsrA and antagonizes its activity in Escherichia coli. J Biol Chem 272: 17502-17510.
95. Henderson IR, Lam AC (2001) Polymorphic proteins of Chlamydia spp. - Autotransporters beyond the Proteobacteria. Trends Microbiol 9: 573-578.
96. Grimwood J, Olinger L, Stephens RS (2001) Expression of Chlamydia pneumoniae polymorphic membrane protein family genes. Infect Immun 69: 2383-2389.
97. Chopra I, Storey C, Falla TJ, Pearce JH (1998) Antibiotics, peptidoglycan synthesis and genomics: The chlamydial anomaly revisited. Microbiology 144 (Part 10): 2673-2678.
98. Braunstein M, Brown AM, Kurtz S, Jacobs WR Jr (2001) Two non-redundant SecA homologues function in mycobacteria. J Bacteriol 183: 6979-6990.
99. Braunstein M, Espinosa BJ, Chan J, Belisle JT, Jacobs WR Jr (2003) SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol Microbiol 48: 453-464.
100. Polkinghorne A, Hogan RJ, Vaughan L, Summersgill JT, Timms P (2005) Differential expression of chlamydial signal transduction genes in normal and interferon gamma-induced persistent Chlamydophila pneumoniae infections. Microbes Infect 8: 61-72.
101. Mukhopadhyay S, Clark AP, Sullivan ED, Miller RD, Summersgill JT (2004) Detailed protocol for purification of Chlamydia pneumoniae elementary bodies. J Clin Microbiol 42: 3288-3290.
102. Mueller A, O'Rourke J, Chu P, Kim CC, Sutton P, et al. (2003) Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A 100: 12289-12294.
103. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.